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326a Monday, February 17, 2014metabolite, had a higher affinity than fluoxetine, with an IC50 of 29 mM.
Fluoxetine inhibited currents in a frequency-dependent manner, shifted
steady-state inactivation to more hyperpolarized potentials, and slowed the
recovery of Nav1.5 channels from inactivation. Mutating a phenylalanine
(F1760) and a tyrosine (Y1767) in DIV S6, two amino acid residues known
to be essential for class 1 antiarrhythmic drug binding, significantly reduced
the affinity of fluoxetine and its frequency-dependent inhibition. We used a
non-activating Nav1.5 mutant to show that fluoxetine displays open-
channel block behavior. We concluded that fluoxetine blocks Nav1.5 chan-
nels by binding to the class 1 antiarrhythmic site. The blocking of cardiac
Naþ channels should be taken into consideration when prescribing fluoxetine
alone or in association ith other drugs that may be cardiotoxic or for patients
with conduction dsorders.
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The pore-forming a subunit of the voltage-gated Naþ (Nav) channels (Nav1.1-
Nav1.9) provides the basis for electrical excitability in the brain. These Nav
channels are regulated by a number of accessory proteins. One of the important
regulator of Nav channels is intracellular fibroblast growth factor 14 (FGF14), a
member of not-secreted intracellular FGFs (iFGFs; FGF11-13). This iFGF14
acts as an allosteric modulator of the Nav channel and regulates neuronal excit-
ability by controlling Nav channel gating properties and expression.
In pursuit of drug discovery against the FGF14-Nav1.6 channel complex, we
are combining molecular modeling to design peptide-fragments of FGF14,
split-luciferase complementation assay (LCA) to evaluate the potency of these
peptides, and electrophysiology to further validates these peptides as disrupters
of the FGF14/Nav1.6 channel complex. We already have created a FGF14
dimer homology model based on the FGF13 dimer crystal structure and
have showed with in-cell LCA that the FGF14 monomer: monomer interface
overlaps with the FGF14/Nav channel interface. We have also identified key
amino acids in proximity to the FGF14/Nav1.6 interface and show that muta-
tions at these sites affect the Nav channel assembly with the FGF14 monomer
and control the access of small fragment peptides to the interface. Based on
our preliminary data, we hypothesize that FGF14-peptide fragments
mimicking the FGF14 protein will compete with FGF14 for binding to Nav
channels and serve as potential chemical leads for drug development against
Nav channels. The proposed small peptides based on the FGF14:Nav1.6
protein-protein interactions act as allosteric modulators for the Nav channel
functions. These results will provide fundamental new knowledge for the
design of new leads targeting the FGF14/Nav channel complex as a novel
drugs target interface.
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Voltage-dependent sodium channels (Nav1.X) control the rising phase of ac-
tion potentials in excitable cells. Mutational pathologies include epilepsy,
Long QT syndrome, familial autism, and pain insensitivity. This family of
ion channels is regulated by calmodulin (CaM), a small, essential eukaryotic
calcium sensor that contains two highly homologous domains whose affinities
for calcium differ by an order of magnitude. CaM is known to recognize at least
two regions of NaV: the highly conserved inactivation gate between transmem-
brane domains III and IV, and an IQ motif, located in the intracellular C-termi-
nus of the Nav. The IQ motif, which may serve as a CaM ‘‘sink’’, holds CaM
available to quickly re-associate with the inactivation gate upon calcium bind-
ing. High-resolution structures of apo CaM bound to the IQ motifs of NaV1.2,
1.5 and 1.6 show many similarities. However, the free energies of CaM binding
to these motifs are markedly different. In our studies of CaM binding to the IQ
motif of NaV1.2, the C-domain of both apo (calcium-free) and calcium-
saturated CaM bind and calcium binding to CaM lowers its affinity for the
IQ motif. To better understand calcium-mediated feedback control, we con-
ducted thermodynamic analyses of CaM binding to the IQ motif sequences rep-
resenting all 9 members of the human Nav family and the consensus
inactivation gate. CaM binding was detected by monitoring the loss of FRET
intensity of a biosensor containing the IQ motif sandwiched between twoYFP and CFP. The nine sodium channels split into two classes based on their
binding affinity for apo CaM at the IQ motif. We are exploring the roles of in-
dividual residues to determine the positions that are necessary and sufficient to
confer preferential binding of apo or calcium-saturated CaM. Support: NIH
R01 GM57001.
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Voltage-gated Naþ channels (NaChs) are common targets for anti-epileptic
drugs due to their role in the initiation and propagation of action potentials
in central neurons. NaCh blocking agents, such as phenytoin and lamotrigine,
act by blocking peak Naþ current (INa) in voltage- and frequency- dependent
manner. A recent study showed that GS-458967 (GS967) is a potent blocker of
cardiac INa. However, the effects of GS967 on neuronal INa and action poten-
tials were not examined. Thus, using isolated rat cultured hippocampal neurons,
effects of GS967 on neuronal INa and excitability were determined. GS967
(10-1000 nM) caused a voltage- (60 mV) and frequency (10 Hz)-dependent
block of INa with IC50 values of 40.654.0 (n=4, at each concentration) and
477.0553.0 nM (n=4, at each concentration), respectively. However, tonic
block of INa was minimal (7.650.5 % at 1000 nM, n= 4). GS967 decreased
the sustained repetitive firing (SRF) in response to a 1-sec depolarizing current
injection with an IC50 value of 47.852.8 nM (n=3-4, at each concentration).
Consistent with minimal tonic block of INa, the compound had no effect on
the amplitude of the first action potential during SRF (2.250.8 % at 300
nM). Furthermore, GS967 reversibly reduced the epileptiform activity induced
by NMDA activation (removal of extracellular Mg2þ) with an IC50 value of
50.751.4 nM (n=3-5, at each concentration). In addition, the effects of
GS967 on ligand-gated ion channels that are essential for synaptic inhibition
or excitation were tested. GS967 (1000 nM) had no effect on GABA-
activated currents (4.253.4%, n=8). At 1000 nM, GS967 inhibited NMDA-
activated currents by 18.256.2% (n=5). Taken together, these findings provide
preliminary evidence that GS967 could be effective in controlling abnormal
neuronal firing.
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Objective: Mutations in SCN5A, the gene encoding the cardiac sodium chan-
nel, have been linked to many inherited cardiac arrhythmias. We have shown
the existence of dominant-negative mutations in Brugada Syndrome due to in-
teractions between alpha-subunits. Here we investigated whether cardiac so-
dium channel alpha-subunits also display coupled gating in addition to
interacting.
Methods: Biophysical properties were studied by patch-clamp analysis in the
whole-cell configuration.
Results: We used a non-trafficking mutant which can be rescued with mexili-
tine, unveiling a þ15 mV shift in activation compared to WT. When this non-
trafficking mutant was co-expressed with WT, we still saw a shift in activation
compared to WT alone, even though the mutant is not conducting. Therefore
these results demonstrate that the presence of the mutant, affects the activation
of the WT suggesting a gating cooperation between the 2 channels. Then we
wanted to address whether the inactivation gating process was also synergic be-
tween two sodium channel subunits. We used a channel where the C-terminus
was deleted and where inactivation was affected. Expression of this delta-Cter
alone showed altered inactivation kinetics. Surprisingly, when co-transfected
with the trafficking-competent but gating-deficient mutant channel R878C,
the inactivation properties of the mutant were partially rescued. Altogether
these data suggest that the presence of the full C-terminal region provided by
the nonfunctional channel R878C could rescue the inactivation defect of the
delta-Cter channel.
Conclusions: Mutations impairing either activation or inactivation of one
channel can affect the gating properties of the other WT alpha-subunit demon-
strating coupled gating properties between sodium channel alpha-subunits.
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Cinnamaldehyde (CA) is a highly reactive compound that has been used in
experimental models of neurogenic inflammation as specific agonist of the
